No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Sandoz’s Biosimilar Etanercept PBS-Listed
On 1 October 2025, Sandoz’s Erelzi®, biosimilar to Amgen/Pfizer’s Enbrel® (etanercept), was listed on Australia’s Pharmaceutical Benefits Scheme (PBS) in 50mg/mL syringe and pen devices.